China Shineway Pharmaceutical Group Limited

HK$7.46As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2877Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 7.91%
Div yield 19.37%
ROE 10.05%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.68
PE TTM 6.072
TSR TTM 19.54%
Mkt cap HK$5.639B
ROIC 50.26%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.88
5.58%
(10.61%)
Hold 10|2|4|8|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.15
0.15
0.16
0.17
18.39%
25.30%
17.85%
25.91%
Revenue¥M
519.6
510.5
525.4
553.7
4.35%
2.30%
3.85%
10.84%
Peers (US$719.3M)
Cap (US$)
PE
853.5M
8.360x
712.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.941
2.961
2.309
EBIT/Intx
2.226
0.282
0.257
Own earn%
51.20
(24.70)
(20.65)
Sh yield%
38.74
9.78
13.30
Owners
Insiders/Inst%
2.99
82.68
Short interest%
1.17
SBC / revenue%
1.25
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
14–23
$1 testx
—
Incr. ROIC%
0